Company Profile

Intranasal Therapeutics, Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative nasally delivered pharmaceutical products, with a particular focus on drugs treating pain and disorders related to the central nervous system for which there is proven, unsatisfied consumer need. We currently have two lead products in our clinical pipeline, with several others in formulation or preclinical development.

Our goal is to become a leader in the field of intranasal pharmaceuticals by applying our formulation expertise across a broad range of therapeutic areas to create new and differentiated products that improve safety, efficacy and convenience for patients, caregivers and health care professionals.

ITI’s fully integrated nasal drug delivery platform combines proprietary formulation research, clinical and regulatory development, specialized delivery systems, sterile manufacturing and packaging of nasal products. These capabilities and expertise enable us to develop our products efficiently and cost effectively. We will commercialize these products by marketing them ourselves or licensing them to other companies.

Our senior management team collectively has more than 100 years of experience in the pharmaceutical industry and extensive experience with development-stage companies. In addition, ITI has a close working relationship with the University of Kentucky College of Pharmacy, a pioneer in the field of nasal drug delivery.